Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Biolevate

Biolevate

Series A
Paris, FranceSep 2026
Healthtech

Biolevate raised €30M in a Series A round in Sep 2026. The company is based in Paris, France. Investors in the round: EQT Ventures, MSD Global Health Innovation Fund (MGHIF), Orange Ventures and 2 others. Data as of Nov 2026.

← Biolevate
Amount raised
€30M
€30,000,000
Native amount
30,000,000 EUR
Stage
Series A
series a
Investors
5

Provenance & confidence

High confidence
Amount

Reported in EUR — no conversion. €30M

High confidence
Source

tech.eu · own

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

5 named
EQT VenturesMSD Global Health Innovation Fund (MGHIF)Orange VenturesRAISE FranceSTATION F
Date
Sep 2026
Round type
series a
Amount (EUR)
€30M

Other rounds

same company

Related news